Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' USHIYAMA C' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 36 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Nakamura, T; Ushiyama, C; Suzuki, S; Shimada, N; Sekizuka, K; Ebihara, I; Koide, H
      Effect of troglitazone on urinary albumin excretion and serum type IV collagen concentrations in Type 2 diabetic patients with microalbuminuria or macroalbuminuria

      DIABETIC MEDICINE
    2. Nakamura, T; Ushiyama, C; Shimada, N; Hayashi, K; Ebihara, I; Suzaki, M; Koide, H
      Changes in concentrations of type IV collagen and tissue inhibitor of metalloproteinase-1 in patients with paraquat poisoning

      JOURNAL OF APPLIED TOXICOLOGY
    3. Nakamura, T; Ushiyama, C; Takahashi, Y; Tanaka, A; Shimada, N; Ebihara, I; Koide, H
      Effect of dilazep dihydrochloride on urinary albumin excretion in patientswith autosomal dominant polycystic kidney disease

      NEPHRON
    4. Nakamura, T; Ushiyama, C; Shimada, N; Sekizuka, K; Ebihara, I; Hara, M; Koide, H
      Effect of cyclophosphamide or azathioprine on urinary podocytes in patients with diffuse proliferative lupus nephritis

      NEPHRON
    5. Ushiyama, C; Nakamura, T; Suzuki, S; Shimada, N; Sekizuka, K; Ebihara, I; Koide, H
      Effect of mizoribine on serum IgE concentration in patients with IgA nephropathy

      NEPHRON
    6. Nakamura, T; Ushiyama, C; Osada, S; Hara, M; Shimada, N; Koide, H
      Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria

      METABOLISM-CLINICAL AND EXPERIMENTAL
    7. Nakamura, T; Ushiyama, C; Shimada, N; Hayashi, K; Ebihara, I; Koide, H
      Comparative effects of pioglitazone, glibenclamide, and voglibose on urinary endothelin-1 and albumin excretion in diabetes patients

      JOURNAL OF DIABETES AND ITS COMPLICATIONS
    8. Nakamura, T; Ushiyama, C; Suzuki, S; Hara, M; Shimada, N; Ebihara, I; Koide, H
      Urinary excretion of podocytes in patients with diabetic nephropathy

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    9. Nakamura, T; Ushiyama, C; Suzuki, S; Shoji, H; Shimada, N; Ebihara, I; Koide, H
      Effect of polymyxin B immobilized fiber on encephalopathy in hemodialysis patients with sepsis

      RENAL FAILURE
    10. Nakamura, T; Ushiyama, C; Suzuki, S; Shoji, H; Shimada, N; Ebihara, I; Koide, H
      Polymyxin B-immobilized fiber reduces increased plasma endothelin-1 concentrations in hemodialysis patients with sepsis

      RENAL FAILURE
    11. Nakamura, T; Ushiyama, C; Suzuki, S; Shimada, N; Ebihara, I; Suzaki, M; Takahashi, T; Koide, H
      Effect of plasma exchange on serum tissue inhibitor of metalloproteinase 1and cytokine concentrations in patients with fulminant hepatitis

      BLOOD PURIFICATION
    12. Nakamura, T; Ushiyama, C; Suzuki, S; Hara, M; Shimada, N; Sekizuka, K; Ebihara, I; Koide, H
      Effects of angiotensin-converting enzyme inhibitor, angiotensin II receptor antagonist and calcium antagonist on urinary podocytes in patients with IgA nephropathy

      AMERICAN JOURNAL OF NEPHROLOGY
    13. Nakamura, T; Ushiyama, C; Suzuki, S; Hara, M; Shimada, N; Ebihara, I; Koide, H
      The urinary podocyte as a marker for the differential diagnosis of idiopathic focal glomerulosclerosis and minimal-change nephrotic syndrome

      AMERICAN JOURNAL OF NEPHROLOGY
    14. Nakamura, T; Ushiyama, C; Suzuki, S; Ebihara, I; Shimada, N; Koide, H
      Elevation of serum levels of metalloproteinase-1, tissue inhibitor of metalloproteinase-1 and type IV collagen, and plasma levels of metalloproteinase-9 in polycystic kidney disease

      AMERICAN JOURNAL OF NEPHROLOGY
    15. Nakamura, T; Ushiyama, C; Shimada, N; Sekizuka, K; Ebihara, I; Hara, M; Koide, H
      Effect at the antiplatelet drug dilazep dihydrochloride on urinary podocytes in patients in the early stage at diabetic nephropathy

      DIABETES CARE
    16. Nakamura, T; Ushiyama, C; Shimada, N; Sekizuka, K; Ebihara, I; Koide, H
      Effects of the angiotensin II receptor antagonist candesartan cilexetil onblood pressure and proteinuria in patients with autosomal dominant polycystic kidney disease

      NEPHRON
    17. Nakamura, T; Ushiyama, C; Suzuki, S; Shoji, H; Shimada, N; Sekizuka, K; Ebihara, I; Koide, H
      Effect of polymyxin B-immobilized fiber hemoperfusion on sepsis-induced rhabdomyolysis with acute renal failure

      NEPHRON
    18. Shimada, N; Nakamura, T; Ushiyama, C; Suzuki, S; Sekizuka, K; Ebihara, I; Koide, H
      Serum KL-6 concentrations in hemodialysis patients with idiopathic interstitial pneumonitis

      NEPHRON
    19. Nakamura, T; Ushiyama, C; Suzuki, S; Shimada, N; Sekizuka, K; Ebihara, I; Takahashi, Y; Tanaka, A; Koide, H
      Comparison between the angiotensin II receptor antagonist candesartan cilexetil and the angiotensin-converting enzyme inhibitor trandolapril in microalbuminuria of patients with early diabetic nephropathy

      NEPHRON
    20. Ebihara, I; Nakamura, T; Suzuki, S; Ushiyama, C; Shimada, N; Suzaki, M; Koide, H
      Effect of dilazep dihydrochloride on plasma P-selectin concentrations in patients with IgA nephropathy

      NEPHRON
    21. Ebihara, I; Nakamura, T; Ushiyama, C; Suzuki, S; Shimada, N; Hara, M; Koide, H
      Urinary podocytes in patients with chronic renal failure

      NEPHRON
    22. Nakamura, T; Ushiyama, C; Suzuki, S; Hara, M; Shimada, N; Sekizuka, K; Ebihara, I; Koide, H
      Urinary podocytes for the assessment of disease activity in lupus nephritis

      AMERICAN JOURNAL OF THE MEDICAL SCIENCES
    23. Nakamura, T; Ebihara, I; Shoji, H; Ushiyama, C; Suzuki, S; Koide, H
      Treatment with polymyxin B-immobilized fiber reduces platelet activation in septic shock patients: Decrease in plasma levels of soluble P-selectin, platelet factor 4 and beta-thromboglobulin

      INFLAMMATION RESEARCH
    24. Abe, K; Takasaki, Y; Ushiyama, C; Asakawa, J; Fukazawa, T; Seki, M; Hirashima, M; Ogaki, M; Hashimoto, H
      Expression of CD80 and CD86 on peripheral blood T lymphocytes in patients with systemic lupus erythematosus

      JOURNAL OF CLINICAL IMMUNOLOGY
    25. Hattori, K; Hirano, T; Ushiyama, C; Miyajima, H; Yamakawa, N; Ikeda, S; Yoshino, K; Tateno, M; Oshimi, K; Kayagaki, N; Yagita, H; Okumura, K
      A metalloproteinase inhibitor prevents acute graft-versus-host disease in mice after bone marrow transplantation

      BONE MARROW TRANSPLANTATION
    26. Nakamura, T; Ushiyama, C; Suzuki, S; Shimada, N; Ohmuro, H; Ebihara, I; Koide, H
      Effects of taurine and vitamin E on microalbuminuria, plasma metalloproteinase-9. and serum type IV collagen concentrations in patients with diabeticnephropathy

      NEPHRON
    27. Ebihara, I; Nakamura, T; Ushiyama, C; Suzuki, S; Shimada, N; Koide, H
      Effect of oral adsorbent AST-120 on plasma metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 concentrations in chronic renal failure

      NEPHRON
    28. Ebihara, I; Nakamura, T; Ushiyama, C; Suzuki, S; Koide, H
      Failure of urinary and serum hepatocyte growth faster assay as an early marker of diabetic nephropathy

      NEPHRON
    29. Nakamura, T; Ebihara, I; Shimada, N; Suzuki, S; Ushiyama, C; Shoji, H; Koide, H
      Effects of hemoperfusion with polymyxin B-immobilized fibre on serum neopterin and soluble interleukin-2 receptor concentrations in patients with septic shock

      JOURNAL OF INFECTION
    30. SEKI M; USHIYAMA C; ABE K; SETA N; FUKAZAWA T; ASAKAWA J; TAKASAKI Y; HASHIMOTO H
      IN-VITRO CELLULAR-DRUG RESISTANCE AND INCREASED EXPRESSION OF BCL-2 IN LYMPHOCYTES FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS

      Arthritis and rheumatism
    31. SEKI M; USHIYAMA C; SETA N; ABE K; FUKAZAWA T; ASAKAWA J; TAKASAKI Y; HASHIMOTO H
      APOPTOSIS OF LYMPHOCYTES INDUCED BY GLUCOCORTICOIDS AND RELATIONSHIP TO THERAPEUTIC EFFICACY IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS

      Arthritis and rheumatism
    32. HATTORI K; HIRANO T; USHIYAMA C; MIYAJIMA H; YAMAKAWA N; EBATA T; WADA Y; IKEDA S; YOSHINO K; TATENO M; OSHIMI K; KAYAGAKI N; YAGITA H; OKUMURA K
      A METALLOPROTEINASE INHIBITOR PREVENTS LETHAL ACUTE GRAFT-VERSUS-HOSTDISEASE IN MICE

      Blood
    33. MIYAJIMA H; ABE K; USHIYAMA C; OKUMURA K; OVARY Z; HIRANO T
      IGE ALLOTYPES IN SERA OF MICE WITH AUTOIMMUNE-DISEASES AND IN MICE WITH GRAFT-VERSUS-HOST DISEASE AFTER TRANSFUSION OR BONE-MARROW TRANSPLANTATION

      International archives of allergy and immunology
    34. MIYAUCHI T; HIRANO T; USHIYAMA C; OVARY Z; OKUMURA K; KATAYAMA H
      ANAPHYLACTIC IGE AND IGG(1) PRODUCTION FOR HAPTEN CAN BE ENHANCED BY CONTRAST-MEDIA

      British journal of radiology
    35. ABE K; SEKI M; USHIYAMA C; FUKAZAWA T; YASUDA M; OGAKI M; TAKASAKI Y; HASIMOTO H
      EXPRESSION OF COSTIMULATORY MOLECULES, CD80 AND CD86, ON PERIPHERAL-BLOOD T-CELLS IN LUPUS PATIENTS

      Arthritis and rheumatism
    36. USHIYAMA C; HIRANO T; MIYAJIMA H; OKUMURA K; OVARY Z; HASHIMOTO H
      ANTI-IL-4 ANTIBODY PREVENTS GRAFT-VERSUS-HOST DISEASE IN MICE AFTER BONE-MARROW TRANSPLANTATION - THE IGE ALLOTYPE IS AN IMPORTANT MARKER OF GRAFT-VERSUS-HOST DISEASE

      The Journal of immunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/01/21 alle ore 13:09:49